Artificial intelligence and deep learning in ophthalmology
By Daniel Shu Wei Ting, L. Pasquale, Lily H. Peng, J. P. Campbell, Aaron Y. Lee, R. Raman, G. Tan, L. Schmetterer, Pearse A. Keane, Tien Yin Wong. British Journal of Ophthalmology, 2018
1,314 citations recorded by the source corpus.
Artificial intelligence (AI) based on deep learning (DL) has sparked tremendous global interest in recent years. DL has been widely adopted in image recognition, speech recognition and natural language processing, but is only beginning to impact on healthcare. In ophthalmology, DL has been applied to fundus photographs, optical coherence tomography and visual fields, achieving robust classification performance in the detection of diabetic retinopathy and retinopathy of prematurity, the glaucoma-like disc, macular oedema and age-related macular degeneration. DL in ocular imaging may be used in conjunction with telemedicine as a possible solution to screen, diagnose and monitor major eye diseases for patients in primary care and community settings. Nonetheless, there are also potential challenges with DL application in ophthalmology, including clinical and technical challenges, explainability of the algorithm results, medicolegal issues, and physician and patient acceptance of the AI ‘black-box’ algorithms. DL could potentially revolutionise how ophthalmology is practised in the future. This review provides a summary of the state-of-the-art DL systems described for ophthalmic applications, potential challenges in clinical deployment and the path forward.
View Paper: https://www.semanticscholar.org/paper/2d9597a69e58b27ffb8531abb885da62432666d3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Chiwei Ong
- Milan Toma
- Jonathan Mayer
- M. Bekbolatova
Citations in the corpus
- Transformative Potential of AI in Healthcare: Definitions, Applications, and Navigating the Ethical Landscape and Public Perspectives (2024, background): “However, deep learning screening tools can accurately classify individuals with DR at a statistically significant rate of 96.8% [68].”